RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management

Blood

Volumn 116, Issue 15, 2010, Pages 2836-2838

  Fasano, Ross M ^a,b   Monaco, Alessandro ^b   Meier, Emily Riehm ^a   Pary, Philippe ^a   Hallie Lee Stroka, A ^b   Otridge, John ^c   Klein, Harvey G ^b   Marincola, Francesco M ^b   Kamani, Naynesh R ^a   Luban, Naomi L C ^a   Stroncek, David ^b   Flegel, Willy A ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Progenika   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN S; LEUKOCYTE ANTIGEN; RHESUS ANTIGEN; BLOOD GROUP RHESUS SYSTEM;

AFRICAN AMERICAN; ANTIBODY TITER; ARTICLE; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; CASE REPORT; CHILD; CROSS REACTION; DONOR SELECTION; ERYTHROCYTE TRANSFUSION; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MALE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; SICKLE CELL ANEMIA; STROKE; ANEMIA, SICKLE CELL; BLOOD; BLOOD GROUP RHESUS SYSTEM; GENETIC POLYMORPHISM; GENETICS;

AFRICAN AMERICANS; ANEMIA, SICKLE CELL; CHILD; DONOR SELECTION; ERYTHROCYTE TRANSFUSION; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; POLYMORPHISM, GENETIC; RH-HR BLOOD-GROUP SYSTEM;

EID: 77957951925     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-279372     Document Type: Article

References (15)

1. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42(1):37-43.
2. Smith-Whitley K. Alloimmunization in patients with sickle cell disease. In: Manno CS, ed. Pediatric Transfusion Therapy. Bethesda, MD: AABB Press, 2002:249-282.
3. Perseghin P, Balduzzi A, Galimberti S, et al. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32(2):231-236. (Pubitemid 36903449)
4. Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood. 2002;100(12):4223-4231.
5. Pham BN, Peyrard T, Tourret S, et al. Anti-Hr and anti-hr revisited. Transfusion. 2009;49(11):2400-2405.
6. Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110(7):2749-2756.
7. Shenoy S. Has stem cell transplantation come of age in the treatment of sickle cell disease? Bone Marrow Transplant. 2007;40(9):813-821.
8. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion. 2008;48(11):2461-2475.
9. Shenoy S, Grossman WJ, DiPersio J, et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant. 2005;35(4):345-352.
10. Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7(12):665-673.
11. Honig M, Flegel WA, Schwarz K, et al. Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens. Bone Marrow Transplant. 2010;45(1):209-211.
12. Klapper E, Zhang Y, Figueroa P, et al. Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion. 2010;50(3):536-546.
13. Moulds J, Lowery C. Frequency and clinical relevance of the r's allele in blacks. Transfusion. 2007;47(S3):156A.
14. Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion. 2010;50(1):13-19.
15. Vege S, Westhoff CM. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology. 2006;22(3):143-147. (Pubitemid 44655954)